Our recent work (McQuail & Burk, 2006) suggests that cholinergic muscarinic receptors, particularly the muscarinic M1 receptor, are important for mediating the effects of the cortical acetylcholine on ...

Defects in the cholinergic signaling pathway have been shown to underlie Alzheimer’s disease and its symptoms.

Our recent work (McQuail & Burk, 2006) suggests that cholinergic muscarinic receptors, particularly the muscarinic M1 receptor, are important for mediating the effects of the cortical acetylcholine on ...

M1 receptors, present on the cholinergic ganglia, with the role of facilitating neural transmission; M2 receptors, located on the postganglion endings of the cholinergic fibers, with the role of ...

This treatment is a new class of medication that targets cholinergic receptors instead of dopamine receptors in the brain. The FDA based its approval on the findings of two identical clinical trials.

Reversible acetylcholinesterase inhibitor (benzazepine deriv). Galantamine, a tertiary alkaloid, is a competitive and reversible inhibitor of acetylcholinesterase. While the precise mechanism of ...